BioNano Genomics saw the highest growth of 2.99% in patent filings and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of BioNano Genomics‘s patent filings and grants. Buy the databook here.
BioNano Genomics has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 14% filings and 100% grants. The World Intellectual Property Organization(WIPO), Australia(AU), United States(US), and Japan(JP) patent Office are among the top ten patent offices where BioNano Genomics is filings its patents. Among the top granted patent authorities, BioNano Genomics has 100% of its grants in United States(US).
Thermo Fisher Scientific and Roche could be the strongest competitors for BioNano Genomics
Patents related to industrial automation and genomics lead BioNano Genomics's portfolio
BioNano Genomics has the highest number of patents in industrial automation followed by, genomics and nanomedicine. For industrial automation, nearly 60% of patents were filed and 50% of patents were granted in Q2 2024.
For comprehensive analysis of BioNano Genomics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.